THU360 Hyperglycemic DKA In Patient On Monotherapy With SGLT-2 Inhibitor

Disclosure: S. Ahmed: None. L. Medina Mora: None. A. Sanchez Ruiz: None. L. Poretsky: None. Background: SGLT2 inhibitors have a rare but increasingly reported risk of euglycemic diabetic ketoacidosis. Hyperglycemic diabetic ketoacidosis is not an expected risk of SGLT-2 inhibitors. Clinical Case: 52...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Samihah, Medina Mora, Luis, Sanchez Ruiz, Angelica, Poretsky, Leonid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553708/
http://dx.doi.org/10.1210/jendso/bvad114.793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553708/
http://dx.doi.org/10.1210/jendso/bvad114.793

Ejemplares similares